Future research into abnormal uterine bleeding

Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 21, Issue 6, 2007, Pages 1023-1040

  Samuel, Nadia C ^a   Justin Clark, T ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

abnormal uterine bleeding; cost effectiveness; diagnosis; effectiveness; fibroids; menorrhagia; research

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTIGESTAGEN; ASOPRISNIL; DESMOPRESSIN ACETATE; GESTAGEN; LEVONORGESTREL; MEFENAMIC ACID; MIFEPRISTONE; OCTIM; PROGESTERONE; PROGESTERONE RECEPTOR MODULATOR; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

AMBULATORY CARE; AMENORRHEA; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MECHANISM; ECHOGRAPHY; ECONOMIC EVALUATION; ELECTROSURGERY; ENDOMETRIUM ABLATION; ENDOMETRIUM HYPERPLASIA; ENDOSCOPIC THERAPY; FEMALE; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MEDICAL TECHNOLOGY; MENOPAUSAL SYNDROME; MENORRHAGIA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; MYOMECTOMY; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; OUTPATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RESOURCE ALLOCATION; REVIEW; SCREENING TEST; UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING; UTERUS MYOMA;

BIOMEDICAL RESEARCH; BLOOD COAGULATION DISORDERS; FEMALE; HUMANS; LEIOMYOMA; MENORRHAGIA; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UTERINE HEMORRHAGE; UTERINE NEOPLASMS;

EID: 36549057688     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2007.03.018     Document Type: Review

References (70)

1. Spencer C.P., and Whitehead M.I. Endometrial assessment re-visited. Br J Obstet Gynaecol 106 (1999) 623-632
2. Bradlow J., Coulter A., and Brooks P. Patterns of referral (1992), Oxford Health Services Research Unit, Oxford
3. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health. 1981-1982 Morbidity statistics from general practice. Third National Study: socioeconomic analysis. Series 5 (1990), HMSO, London
4. Department of Health. Referral guidelines for suspected cancer (1999), Department of Health, London. http://www.doh.gov.uk/cancer Available at: http://www.doh.gov.uk/cancer. Accessibility verified 27 September 2002.
5. Cuschieri A. Minimal access therapy: scope, evaluation and future direction. Health Bull 54 (1996) 514-521
6. Clark T.J., Mahajan D., Sunder P., et al. What research should be done in gynaecological endoscopy: a national questionnaire survey of members of the British Society of Gynaecological Endoscopy. Gynaecol Endosc 10 (2002) 297-301
7. Fryback D.G., and Thornbury J.R. The efficacy of diagnostic imaging. Med Decision Making 11 (1991) 88-94
8. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 138 (2003) W1-W12
9. Marjoribanks J., Lethaby A., and Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2 (2006) CD003855
10. Hurskainen R., Teperi J., Rissanen P., et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 357 (2001) 273-277
11. Hurskainen R., Teperi J., Rissanen P., et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 291 (2005) 1456-1463
12. Lamping D.L., Rowe P., Clarke A., et al. Development and validation of the menorrhagia outcomes questionnaire. Br J Obstet Gynecol 105 (1998) 766-779
13. Shaw R.W., Brickley M.R., Evans L., et al. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. Br J Obstet Gynecol 105 (1998) 1155-1159
14. Hallberg L., and Nilsson L. Constancy of individual menstrual blood loss. Acta Obstet Gynecol Scand 43 (1964) 352-359
15. Higham J.M., O'Brien P.M., and Shaw R.W. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97 (1990) 734-739
16. Quinn M, Babb P, Brock A et al. Cancer trends in England and Wales 1950-1999. London: Office of National Statistics; 2001. Available at: http://www.statistics.gov.uk/downloads/theme_health/cancertrends_5099.pd f. Accessed 14 January 2002.
17. Peto V., Coulter A., and Bond A. Factors affecting general practitioners' recruitment of patients into a prospective study. Fam Pract 10 (1993) 207-211
18. Coulter A., Kelland J., Long A., et al. The management of menorrhagia. Eff Health Care 9 (1995) 1-16
19. Fender G.R., Prentice A., Gorst T., et al. Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. BMJ 318 (1999) 1246-1250
20. Coulter A., Bradlow J., Agass M., et al. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol 98 (1991) 789-796
21. Grant C., Gallier L., Fahey T., et al. Management of menorrhagia in primary care-impact on referral and hysterectomy: data from the Somerset Morbidity Project. J Epidemiol Community Health 54 (2000) 709-713
22. McAlister F., Straus S., and Sackett D. Why we need large, simple studies of the clinical examination: the problem and a proposed solution. Lancet 354 (1999) 1721-1724
23. Clark T.J., Bakour S., Gupta J.K., et al. Evaluation of outpatient hysteroscopy and ultrasonography in the diagnosis of endometrial disease. Obstet Gynecol 99 (2002) 1001-1007
24. Bachmann L.M., Clark T.J., ter Riet G., et al. Diagnostic probability estimation for a combination of tests: an approach to diagnosis of endometrial hyperplasia and cancer in postmenopausal bleeding. Acta Obstet Gynecol Scand 82 (2003) 564-569
25. James A.H., Lukes A.S., Brancazio L.R., et al. Use of a new platelet function analyzer to detect von Willebrand disease in women with menorrhagia. Am J Obstet Gynecol 191 (2004) 449-455
26. Royal College of Obstetricians and Gynaecologists. The management of menorrhagia in secondary care. Evidence-based clinical guideline No 5 (1999), RCOG Press, London
27. Clark T.J., Barton P.M., Coomarasamy A., et al. Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies. Br J Obstet Gynaecol 113 (2006) 502-510
28. Dijkhuizen F.P., Mol B.W., Bongers M.Y., et al. Cost-effectiveness of transvaginal sonography and saline infused sonography in the evaluation of menorrhagia. Int J Gynaecol Obstet 83 (2003) 45-52
29. Lethaby A., Farquhar C., and Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 4 (2000) CD000249
30. Lethaby A., Augood C., and Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 3 (1998) CD000400
31. Lethaby A.E., Cooke I., and Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 4 (2005) CD002126
32. Clark T.J., Neelakantan D., and Gupta J.K. The management of endometrial hyperplasia: an evaluation of current practice. Eur J Obstet Gynecol Reprod Biol 125 (2006) 259-264
33. Steinauer J., Pritts E.A., Jackson R., et al. Systematic review of mifepristone for the treatment of uterine leiomyomata. Obstet Gynaecol 103 (2004) 1331-1336
34. Chwalisz K., Elger W., Stickler T., et al. The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women. Hum Reprod 20 (2005) 1090-1099
35. Chwalisz K., DeManno D., Garg R., et al. Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata. Semin Reprod Med 22 (2004) 113-119
36. Coulter A., Bradlow J., Agass M., et al. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol 98 (1991) 789-796
37. Grant C., Gallier L., Fahey T., et al. Management of menorrhagia in primary care -impact on referral and hysterectomy: data from the Somerset Morbidity Project. J Epidemiol Community Health 54 (2005) 709-713
38. Wingo P.A., Huezo C.M., Rubin G.L., et al. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 152 (1985) 803-808
39. McPherson K., Metcalfe M.A., Herbert A., et al. Severe complications of hysterectomy: the VALUE study. Br J Obstet Gynaecol 111 (2004) 688-694
40. Clark T.J., and Gupta J.K. Handbook of outpatient hysteroscopy: a complete guide to diagnosis and therapy (2005), Hodder Arnold, London. Available at: http://www.rcog.org.uk/index.asp?PageID=73&BookCategoryID=4&Book TypeID=23&BookDetailsID=1488
41. Busfield R.A., Farquhar C.M., Sowter M.C., et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. Br J Obstet Gynaecol 113 (2006) 257-263
42. Brown P.M., Farquhar C.M., Lethaby A., et al. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. Br J Obstet Gynaecol 113 (2006) 797-803
43. Clark T.J., Godwin J., Khan K.S., et al. Ambulatory endoscopic treatment of symptomatic benign endometrial polyps: a feasibility study. Gynaecol Endosc 11 (2002) 91-97
44. Clark T.J., Khan K.S., and Gupta J.K. Current practice for the treatment of benign intrauterine polyps: a national questionnaire survey of consultant gynaecologists in the UK. Eur J Obstet Gynaecol Reprod Biol 103 (2002) 65-67
45. Farrugia M., and Hussain S.Y. Hysteroscopic endometrial ablation using the Hydro ThermAblator in an outpatient hysteroscopy clinic: feasibility and acceptability. J Minim Invasive Gynecol 13 (2006) 178-182
46. Jack S.A., Cooper K.G., Seymour J., et al. A randomised controlled trial of microwave endometrial ablation without endometrial preparation in the outpatient setting: patient acceptability, treatment outcome and costs. Br J Obstet Gynaecol 112 (2005) 1109-1116
47. Clark T.J., and Gupta J.K. Outpatient thermal balloon ablation of the endometrium. Fertil Steril 82 (2004) 1395-1401
48. Garry R., Fountain J., Mason S., et al. The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ 328 (2004) 129
49. Johnson N., Barlow D., Lethaby A., et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev (2005). http://doi:10.1002/14651858.CD003677.pub3 doi:10.1002/14651858.CD003677.pub3
50. Thiel J., and Gamelin A. Outpatient total laparoscopic hysterectomy. J Am Assoc Gynecol Laparosc 10 (2003) 481-483
51. Levy B.S., Luciano D.E., and Emery L.L. Outpatient vaginal hysterectomy is safe for patients and reduces institutional cost. J Minim Invasive Gynecol 12 (2005) 494-501
52. Thiel J.A., and Kamencic H. Assessment of costs associated with outpatient total laparoscopic hysterectomy. J Obstet Gynaecol Can 28 (2006) 794-798
53. Lieng M., Istre O., Langebrekke A., et al. Outpatient laparoscopic supracervical hysterectomy with assistance of the lap loop. J Minim Invasive Gynecol 12 (2005) 290-294
54. National Institute for Clinical Excellence. Uterine artery embolisation for the treatment of uterine fibroids (2004), NICE, London
55. Coleman P., and Ayiku L. Systematic review of the efficacy and safety of uterine artery embolisation in the treatment of fibroids (2004), Review Body for Interventional Procedures, Sheffield
56. Sulaiman S., Khaund A., McMillan N., et al. Uterine fibroids-do size and location determine menstrual blood loss?. Eur J Obstet Gynecol Reprod Biol 115 (2004) 85-89
57. Hart R., Molnar B.G., and Magos A. Long term follow-up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol 106 (1999) 700-705
58. Emanuel M.H., Wamsteker K., Hart A.A., et al. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 93 (1999) 743-748
59. Overton C., Hargreaves J., and Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Br J Obstet Gynecol 104 (1997) 1351-1359
60. Clark T.J., Mahajan D., Sunder P., et al. Hysteroscopic treatment of symptomatic submucous fibroids using a bipolar intrauterine system: a feasibility study. Eur J Obstet Gynecol Reprod Biol 100 (2002) 237-242
61. Istre O. Uterine artery occlusion for the treatment of symptomatic fibroids: endoscopic, radiological and vaginal approach. Minim Invasive Ther Allied Technol 14 (2005) 167-174
62. Vilos G.A., Vilos E.C., Romano W., et al. Temporary uterine artery occlusion for treatment of menorrhagia and uterine fibroids using an incisionless Doppler-guided transvaginal clamp: case report. Hum Reprod 21 (2006) 269-271
63. Zupi E., Marconi D., Sbracia M., et al. Directed laparoscopic cryomyolysis for symptomatic leiomyomata: one-year follow up. J Minim Invasive Gynecol 12 (2005) 343-346
64. Holzer A., Jirecek S.T., Illievich U.M., et al. Laparoscopic versus open myomectomy: a double-blind study to evaluate postoperative pain. Anesth Analg 102 (2006) 1480-1484
65. Alessandri F., Lijoi D., Mistrangelo E., et al. Randomized study of laparoscopic versus minilaparotomic myomectomy for uterine myomas. J Minim Invasive Gynecol 13 (2006) 92-97
66. Mais V., Ajossa S., Guerriero S., et al. Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome. Am J Obstet Gynecol 174 (1996) 654-658
67. Hald K., Klow N.E., Qvigstad E., et al. Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial. Obstet Gynecol 109 (2007) 20-27
68. Sculpher M., Manca A., Abbott J., et al. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial. BMJ 328 (2004) 134
69. Dijkhuizen F.P., Mol B.W., Brolmann H.A., et al. Cost-effectiveness of the use of transvaginal sonography in the evaluation of postmenopausal bleeding. Maturitas 45 (2003) 275-282
70. Wade S.W., Magee G., Metz L., et al. Cost-effectiveness of treatments for dysfunctional uterine bleeding. J Reprod Med 51 (2006) 553-562